TipRanks
HUTCHMED (China) Limited (HK:0013)
:0013
Hong Kong Market
0013
HUTCHMED (China)
RESEARCH TOOLSreports
Want to see HK:0013 full AI Analyst Report?

HUTCHMED (China) (0013) Stock News & Sentiment

8 Followers
HUTCHMED Backs AstraZeneca’s U.S. Filing for ORPATHYS–TAGRISSO Lung Cancer Combo
Premium
Company Announcements
HUTCHMED Backs AstraZeneca’s U.S. Filing for ORPATHYS–TAGRISSO Lung Cancer Combo
14d ago
HUTCHMED launches first-in-human global trial of novel KRAS-EGFR cancer therapy HMPL-A830
Premium
Company Announcements
HUTCHMED launches first-in-human global trial of novel KRAS-EGFR cancer therapy HMPL-A830
15d ago
HUTCHMED to showcase pivotal lung cancer and broad oncology data at ESMO 2026
Premium
Company Announcements
HUTCHMED to showcase pivotal lung cancer and broad oncology data at ESMO 2026
19d ago
HUTCHMED Licenses First-in-Class KRAS-EGFR Cancer Therapy to GSK in US$1.3 Billion Deal
Premium
Company Announcements
HUTCHMED Licenses First-in-Class KRAS-EGFR Cancer Therapy to GSK in US$1.3 Billion Deal
1M ago
HUTCHMED’s ORPATHYS–TAGRISSO Combo Delivers First-Line PFS Gain in MET-Driven Lung Cancer
Premium
Company Announcements
HUTCHMED’s ORPATHYS–TAGRISSO Combo Delivers First-Line PFS Gain in MET-Driven Lung Cancer
1M ago
HUTCHMED’s ORPATHYS Combo Delivers First-Line Benefit in MET-Driven Lung Cancer
Premium
Company Announcements
HUTCHMED’s ORPATHYS Combo Delivers First-Line Benefit in MET-Driven Lung Cancer
1M ago
HUTCHMED Wins China NMPA Nod for ATLED in Advanced Liver Cancer
Premium
Company Announcements
HUTCHMED Wins China NMPA Nod for ATLED in Advanced Liver Cancer
2M ago
More HK:0013 News >

0013 News on the Web

Hutchmed initiates Phase Ia part of trial of HMPL-A830
TipRanks News
Bullish
Citic Securities Remains a Buy on HUTCHMED (China) (HCM)
TipRanks News
Bullish
Huatai Securities Keeps Their Buy Rating on HUTCHMED (China) (HCM)
TipRanks News
Bullish
Positive Report for HUTCHMED (China) (HCM) from Daiwa
TipRanks News
Bullish
HUTCHMED shares jump 17% on US$1.3 billion GSK cancer drug deal
Proactive Investors
Bullish
HUTCHMED Licenses First-in-Class KRAS-EGFR Cancer Therapy to GSK in US$1.3 Billion Deal
TipRanks News
Bullish
HUTCHMED Flags Director’s Link to Insolvent Israeli Medtech Firm, Sees No Impact
TipRanks News
Neutral
Hutchmed announces results from Saffron Phase III trial of Orpathys, Tagrisso
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average2.5 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:0013’s Media Buzz Sentiment?
Currently, no data Available
What is HK:0013’s weekly average amount of articles?
In an average week, 2.5 articles about HK:0013 are published.
    What is HK:0013’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    IQVIQVIA Holdings
    GILDGilead Sciences
    ABBVAbbVie
    VRTXVertex Pharmaceuticals
    NVSNovartis
    Showing the stocks with the most bullish news sentiment over the past week